Portfolio
Zhejiang Hangkang Pharmaceutical
Zhejiang Hangkang Pharmaceutical Co., Ltd. is one of the first batch of key high-tech enterprises in Zhejiang Province. The company is located in the New Drug Port of Hangzhou Economic and Technological Development Zone, Zhejiang, with a total area of ​​53,000 square meters. It is mainly engaged in the research and development, manufacturing and Sales, currently have freeze-dried powder injection (freeze-dried powder), capsules, tablets, granules, liquids and other production lines, all of which have passed the 2010 version of GMP certification.
The company now has more than 30 drug approval numbers for nervous system drugs, hemostatic drugs, anti-infective drugs, etc. Among them: Xien Kai "Fufang Haishe Capsules" is the first marine biological nootropic drug in China, and the national exclusive protection of traditional Chinese medicine. Won the national key new product, and was included in the national high-tech industrialization demonstration project; other products such as "thrombin", "concentrated tinidazole gargle", "zinc gluconate granules" are listed in the national The medical insurance catalogue has a high reputation and recognition among similar products in China.
The company carried out asset restructuring at the end of 2008. With the strong support of the new controlling shareholder, the company has increased investment in new product development, continuously improved its management level and market competitiveness, and is committed to becoming a high-end traditional Chinese medicine for middle-aged and elderly chronic diseases in China. Brand and pioneer of marine biomedicine, and strive to make its own contribution to the development of the motherland's pharmaceutical industry and the improvement of people's healthy life.